Neharika is an investment analyst and financial journalist with a passion for uncovering actionable investment ideas. Holding a degree in Management Studies, she combines strong analytical skills with a deep interest in finance. Currently pursuing her CFA, she aims to help investors spot untapped opportunities and make informed decisions in an ever-evolving market landscape.
/Qualcomm%2C%20Inc_%20logo%20on%20phone-by%20viewimage%20via%20Shutterstock.jpg)
QUALCOMM has considerably outperformed its sector peers recently, yet analysts remain cautious about the stock’s prospects.
While PepsiCo has considerably underperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
/Advanced%20Micro%20Devices%20Inc_%20logo%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Advanced Micro Devices has significantly outperformed the Nasdaq recently, and analysts remain highly optimistic about the stock’s prospects.
Coca-Cola has underperformed the S&P 500 recently, yet analysts remain highly optimistic about the stock’s prospects.
While Procter & Gamble has notably underperformed the S&P 500 recently, analysts remain moderately optimistic about the stock’s prospects.
/Mastercard%20Incorporated%20cards-by%20llsur%20via%20Shutterstock.jpg)
Although Mastercard has underperformed its industry peers recently, analysts remain highly optimistic about the stock’s prospects.
/Unitedhealth%20Group%20Inc%20%20phone%20and%20site-by%20T_Schneider%20via%20Shutterstock.jpg)
As UnitedHealth Group has considerably outperformed its sector peers recently, analysts remain highly optimistic about the stock’s prospects.
Although Exxon Mobil has underperformed the Dow recently, analysts remain moderately optimistic about the stock’s prospects.
Workday has significantly underperformed the broader market over the past 52 weeks, yet Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.
/Factset%20Research%20Systems%20Inc_%20logo%20on%20keyboard-by%20rafapress%20via%20Shutterstock.jpg)
As FactSet Research Systems has notably lagged the broader market over the past 52 weeks, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
